首页> 外文期刊>AIDS Research and Human Retroviruses >Prevalence of Drug Resistance in Human Immunodeficiency Virus Type 1-Infected Treatment-Naive Children in Pune, India
【24h】

Prevalence of Drug Resistance in Human Immunodeficiency Virus Type 1-Infected Treatment-Naive Children in Pune, India

机译:印度浦那人免疫缺陷病毒型1感染治疗 - 天真儿童的耐药患病率

获取原文
获取原文并翻译 | 示例
           

摘要

We report the presence of drug resistance mutations in 7.4% (2/27) of the treatment-naive, HIV-1-infected children in Pune, India, who had HIV-1 RNA levels > 1,000 copies/ml. Nonnucleoside reverse transcriptase inhibitor (NNRTI) mutations, namely A98G and K103N, were observed in two separate sequences. In addition, three study sequences displayed three separate HIV-1 protease minor resistance mutations—LI01, A71T, and T74S. These preliminary data from Pune, India, reporting the presence of HTVDR in treatment-naive, HTV-1-infected children, reinforces the need to conduct large-scale studies to assess the prevalence of primary HIVDR in the pediatric population, which in turn will aid in planning protocols and policies related to antiretroviral treatment for the pediatric population.
机译:我们报告了7.4%(2/27)的治疗幼稚,HIV-1感染儿童的耐药突变存在的存在抗病,印度,HIV-1 RNA水平> 1,000拷贝/ mL。 在两个单独的序列中观察非核苷逆转录酶抑制剂(NNRTI)突变,即A98G和K103N。 此外,三种研究序列显示三个单独的HIV-1蛋白酶次抗性突变-LI01,A71T和T74s。 来自印度浦那的这些初步数据,报告治疗Naive的HTVDR的存在,加强了进行大规模研究的需要,以评估小儿人群中原发性艾滋病毒症的患病率,这反过来又会 有助于对儿科人群的抗逆转录病毒治疗有关的规划方案和政策。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号